← Evidence map

ArticleJAMA2017

Zoledronic Acid Dosing Interval for Metastatic Cancer.

Tetsuya Tanimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 28399242